2,5-Bis(trifluoromethyl)benzaldehyde CAS 395-64-2 Intende ≥98.0% (GC)

Description:

Nomen chemicum: 2,5-Bis(trifluoromethyl)benzaldehyde

CAS: 395-64-2

Dic: ≥98.0% (GC)

Aspectus: Hyalina seu lux Yellow Perspicuus Liquid

High Quality, Commercialized Production

Contactus: Dr

Mobile/Wechat/Whatsapp: +86-15026746401

E-Mail: alvin@ruifuchem.com

Mitte ad nos inscriptio

Product Detail

Product Tags

Descriptio:

Ruifu Chemical est primarius fabricae 2,5-Bis(trifluoromethyl)benzaldehydae (CAS: 395-64-2) magna qualitate.Ruifu Chemical traditio totius terrarum, quantitatis competitive pretium, optimum servitium, parvas et moles in promptu habere potest.Purchase 2,5-Bis(trifluoromethyl)benzaldehyde,Please contact: alvin@ruifuchem.com

Chemical Properties:

Nomen chemicum	2,5-Bis(trifluoromethyl)benzaldehyde
CAS Number	395-64-2
Stock Status	In Stock, Productio Ascendite usque ad Centum chiliogrammata
Formulae hypotheticae	C9H4F6O
M. Pondus	242.12
Ferveret	137«(lit.)
Density	1.468 g/mL ad 25℃(lit.)
Index refractivus	1.421 at 20℃
Sensitiva	Air Sensitiva
Brand	Ruifu Chemical

Specifications:

Item	Specifications
Aspectus	Hyalina vel lux Yellow Transparens Liquid
Puritas	≥98.0% (GC)
Totalis immunditias	≤2.00%
1H NMR Imaginum	Conformat ut Structure
Test Standard	Enterprise Standard
Consuetudinem	Pharmaceutical intermedia

Sarcina & Repono:

sarcina: Utrem, 25kg/Drum, vel secundum exigentiam emptoris.

Repono Condition:Repone in vasis signatis in loco frigido et sicco;Lucem protege, humorem.

commoda:

FAQ:

395-64-2 - Periculum et Salus;

Periculosam symbola Xi - Irritant
Periculum Codes 36/37/38 - Irritando ad oculos, systema respiratorium et cutem.
Salus Descriptio
S26 - In contactu cum oculis, statim cum aqua multa ablue et consilium medicinae quaeras.
S36/37/39 - Indumentum tutelae idoneum, chirothecae et oculi / faciei tutelam indue.
S37 - gere idoneis caestibus.
S36 - gere idoneos tutelae vestis.
WGK Germania 3
Aleam Nota Irritant

395-64-2 -Applicatio:

2,5-Bis (trifluoromethyl)benzaldehyde (CAS: 395-64-2) summa qualitate, late in synthesi organica adhibita, synthesis intermediorum pharmaceuticae et synthesis Pharmaceuticae Ingredientis activae.